Prescription drug · ANDA
Ampicillin and Sulbactam NDC 0409-2987
ampicillin sodium and sulbactam sodium · Ampicillin sodium 2 g/1; Sulbactam sodium 1 g/1 · Injection, Powder, For solution · Intravenous · Hospira, Inc
NDC codes
FDA NDC DirectoryProduct information
- Brand name (proprietary)
- Ampicillin and Sulbactam
- Generic name (nonproprietary)
- ampicillin sodium and sulbactam sodium
- Active ingredients
- Ampicillin sodium — 2 g/1Sulbactam sodium — 1 g/1
- Dosage form
- Injection, Powder, For solution
- Route
- Intravenous
- Labeler
- Hospira, Inc
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 065310
- Marketing start
- Marketing end
- Other FDA classes
- Penicillins (Chemical structure)beta Lactamase Inhibitors (Mechanism)
- Identifiers
- Product ID 0409-2987_f5c18a44-2ebd-40ba-893b-d6adda64d2b1SPL ID f5c18a44-2ebd-40ba-893b-d6adda64d2b1SPL set ID dc374fa4-350b-425d-a7db-7099fdc64cf1RxCUI 1659592, 1659598UNII DKQ4T82YE6, JFN36L5S8K
- Pharmacologic class
- Penicillin-class Antibacterial; beta Lactamase Inhibitor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Ampicillin and sulbactam for injection is indicated for the treatment of infections due to susceptible strains of the designated microorganisms in the conditions listed below. Skin and Skin Structure Infections caused by beta-lactamase producing strains of Staphylococcus aureus, Escherichia coli,* Klebsiella spp.* (including K. pneumoniae* ), Proteus mirabilis,* Bacteroides fragilis,* Enterobacter spp.,* and Acinetobacter calcoaceticus.* NOTE: For information on use in pediatric patients (see PRECAUTIONS - Pediatric Use and CLINICAL STUDIES sections). Intra-Abdominal Infections caused by beta-lactamase producing strains of Escherichia coli, Klebsiella spp. (including K.…
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 065310
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Ampicillin and Sulbactamampicillin sodium and sulbactam sodium | Ampicillin sodium 1 g/1; Sulbactam sodium .5 g/1 | Injection, Powder, For solutionIntravenous | Hospira, Inc | 0409-2689 |